Parabilis Medicines, Inc. (PBLS)
NASDAQ: PBLS · Real-Time Price · USD
31.96
+0.14 (0.44%)
At close: Jul 28, 2026, 4:00 PM EDT
31.96
0.00 (0.00%)
Pre-market: Jul 29, 2026, 4:58 AM EDT

Parabilis Medicines Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024
Period Ending
Dec '25 Dec '24
Debt / Equity Ratio
-2.291.01
Net Debt / Equity Ratio
-0.060.06
Net Debt / EBITDA Ratio
-0.210.18
Net Debt / FCF Ratio
-0.250.21
Quick Ratio
0.492.73
Current Ratio
0.522.84
Return on Equity (ROE)
-731.00%-208.92%
Return on Assets (ROA)
-132.20%-84.50%
Return on Invested Capital (ROIC)
-219.18%-189.89%
Return on Capital Employed (ROCE)
-215.91%-107.95%
Buyback Yield / Dilution
-4.59%-
Total Shareholder Return
-4.59%-
SEC Filings: 10-K · 10-Q